Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis
Pulsed Electromagnetic Field Therapy (PEMF) Compared to Conventional Mechanical Prophylaxis for Venous Thromboembolism Prophylaxis in Patients in the Intensive Care Unit (ICU)
Science Valley Research Institute
50 participants
May 25, 2025
INTERVENTIONAL
Conditions
Summary
Venous thromboembolism (VTE) is frequent in patients in the intensive care unit (ICU). Pharmacologic prophylaxis is sometimes contraindicated, and mechanical prophylaxis is used. The primary objective of the study is to compare Pulsed Electromagnetic Field Therapy (PEMF) with conventional mechanical prophylaxis for the prevention of VTE in patients in the ICU.
Eligibility
Inclusion Criteria3
- Patients \> 18 years old in ICU
- PADUA score\> 4 (medical patients) and/or Caprini score\> 3 (surgical patients)
- Contraindication to pharmacological prophylaxis or indication to combined (pharmacological and mechanical VTE prophylaxis)
Exclusion Criteria3
- Patients \< 18 years old in ICU
- Unable to use mechanical prophylaxis due to trauma, burns, fracture, or problems in inferior members that prevent the use of mechanical prophylaxis
- Life expectations less than 24 hours
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The PEMF will be carried out using the Hyperslim® device. The Hyperslim® device is produced by Medical San (Lageado, RS, Brazil).
The intermittent pneumatic compression group will use the devices Covidien Kendall SCD 700® (Cardinal Health) or Doctor Life 2600® (Venosan).
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06958588